Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Tóm tắt
Từ khóa
Tài liệu tham khảo
Lievin-Le Moal V, Servin AL: The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin Microbiol Rev 2006, 19:315–337.
• Dharmani P, Srivastava V, Kissoon-Singh V, et al.: Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun 2009, 1:123–135. This article provides a succinct review of the role of mucin in innate host defense against commensal and pathogenic microbiota and the role of intestinal microbes in mucin regulation.
Hollingsworth MA, Swanson BJ: Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004, 4:45–60.
Andrianifahanana M, Moniaux N, Batra SK: Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta 2006, 1765:189–222.
• McGuckin MA, Eri R, Simms LA, et al.: Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009, 15:100–113. This article provides a critical review of the components of the secreted and cellular barrier and their regulation and the evidence of barrier dysfunction in IBD.
• van der Flier LG, Clevers H: Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009, 71:241–260. This article provides a succinct summary of the current view of intestinal stem cells and genetic hierarchy responsible for cell fate commitment and differentiation in normal and diseased intestine.
Velcich A, Yang W, Heyer J, et al.: Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002, 295:1726–1729.
Taupin D, Podolsky DK: Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003, 4:721–732.
Karam SM: Lineage commitment and maturation of epithelial cells in the gut. Front Biosci 1999, 4:D286–298.
Deplancke B, Gaskins HR: Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 2001, 73:1131S–1141S.
Stanger BZ, Datar R, Murtaugh LC, et al.: Direct regulation of intestinal fate by Notch. Proc Natl Acad Sci U S A 2005, 102:12443–12448.
Yang Q, Bermingham NA, Finegold MJ, et al.: Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001, 294:2155–2158.
Park ET, Oh HK, Gum JR, Jr, et al.: HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin Cancer Res 2006, 12:5403–5410.
Davis CW, Dickey BF: Regulated airway goblet cell mucin secretion. Annu Rev Physiol 2008, 70:487–512.
Gum JR, Byrd JC, Hicks JW, et al.: Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 1989, 264:6480–6487.
Gum JR Jr, Hicks JW, Toribara NW, et al.: Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem 1994, 269:2440–2446.
Godl K, Johansson ME, Lidell ME, et al.: The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem 2002, 277:47248–47256.
Lidell ME, Johansson ME, Morgelin M, et al.: The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. Biochem J 2003, 372:335–345.
Gum JR Jr, Ho JJ, Pratt WS, et al.: MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region. J Biol Chem 1997, 272:26678–26686.
Gum JR Jr, Hicks JW, Crawley SC, et al.: Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus. J Biol Chem 2003, 278:49600–49609.
Hattrup CL, Gendler SJ: Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 2008, 70:431–457.
Ho SB, Dvorak LA, Moor RE, et al.: Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. Gastroenterology 2006, 131:1501–1517.
Luu Y, Junker W, Rachagani S, et al.: Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Int J Biochem Cell Biol 2010, 42:996–1006.
Carlstedt I, Sheehan JK: Structure and macromolecular properties of cervical mucus glycoproteins. Symp Soc Exp Biol 1989, 43:289–316.
Kim YS, Deng G: Aberrant expression of carbohydrate antigens in cancer: the role of genetic and epigenetic regulation. Gastroenterology 2008, 135:305–309.
• Brockhausen I, Schacter H, Stanley P: O-GalNAc glycans. In Essentials of Glycobiology. Edited by Varki A, Cummings RD, Esko JD. Woodbury, NY: Cold Spring Harbor Laboratory Press; 2009:115–127. This is a concise review of the structure, biosynthesis, and function of mucin O-glycans.
Theodoropoulos G, Carraway KL: Molecular signaling in the regulation of mucins. J Cell Biochem 2007, 102:1103–1116.
Thai P, Loukoianov A, Wachi S, et al.: Regulation of airway mucin gene expression. Annu Rev Physiol 2008, 70:405–429.
Li J-D, Feng W, Gallup M, et al.: Activation of NF-kB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci U S A 1998, 95:5718–5723.
Ahn DH, Crawley SC, Hokari R, et al.: TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cell Physiol Biochem 2005, 15:29–40.
Iwashita J, Sato Y, Sugaya H, et al.: mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 2003, 81:275–282.
Hokari R, Lee H, Crawley SC, et al.: Vasoactive intestinal peptide upregulates MUC2 intestinal mucin via CREB/ATF1. Am J Physiol Gastrointest Liver Physiol 2005, 289:G949–959.
Gregorieff A, Stange DE, Kujala P, et al.: The ets-domain transcription factor Spdef promotes maturation of goblet and Paneth cells in the intestinal epithelium. Gastroenterology 2009, 137:1333–1345 e1331–1333.
Okudaira K, Kakar S, Cun L, et al.: MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues. Int J Oncol 2010, 36:765–775.
Yamada N, Hamada T, Goto M, et al.: MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer. Int J Cancer 2006, 119:1850–1857.
Atuma C, Strugala V, Allen A, et al.: The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 2001, 280:G922–G929.
Johansson ME, Thomsson KA, Hansson GC: Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J Proteome Res 2009, 8:3549–3557.
Ho SB, Takamura K, Anway R, et al.: The adherent gastric mucous layer is composed of alternating layers of MUC5AC and MUC6 mucin proteins. Dig Dis Sci 2004, 49:1598–1606.
Phillipson M, Johansson ME, Henriksnas J, et al.: The gastric mucus layers: constituents and regulation of accumulation. Am J Physiol Gastrointest Liver Physiol 2008, 295:G806–G812.
Didierlaurent A, Sirard JC, Kraehenbuhl JP, et al.: How the gut senses its content. Cell Microbiol 2002, 4:61–72.
•• Johansson ME, Phillipson M, Petersson J, et al.: The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 2008, 105:15064–15069. This article provides definitive evidences for the presence, identity, and differential microbial association of two mucus layers in mouse colon and for the defective mucus barrier, increased permeability, and susceptibility to experimental colitis in Muc2-deficient mice.
•• Martens EC, Roth R, Heuser JE, et al.: Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J Biol Chem 2009, 284:18445–18457. This article describes a novel regulatory pathway involving O-glycan targeting outer membrane protein on a gut bacterium that governs the coordinated regulation of O-glycan catabolism and capsule synthesis.
Van der Sluis M, De Koning BA, De Bruijn AC, et al.: Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006, 131:117–129.
McAuley JL, Linden SK, Png CW, et al.: MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007, 117:2313–2324.
• Sartor RB: Microbial influences in inflammatory bowel diseases. Gastroenterology 2008, 134:577–594. This is a comprehensive review on intestinal commensal and pathogenic microbiota/host interactions in health and disease and in rodent models of IBD.
Frank DN, St Amand AL, Feldman RA, et al.: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780–13785.
Qin J, Li R, Raes J, et al.: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59–65.
Moncada DM, Kammanadiminti SJ, Chadee K: Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol 2003, 19:305–311.
Fukata M, Abreu MT: Pathogen recognition receptors, cancer and inflammation in the gut. Curr Opin Pharmacol 2009, 9:680–687.
Mack DR, Michail S, Wei S, et al.: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999, 276:G941–G950.
Sherman PM, Ossa JC, Johnson-Henry K: Unraveling mechanisms of action of probiotics. Nutr Clin Pract 2009, 24:10–14.
Kjellev S: The trefoil factor family—small peptides with multiple functionalities. Cell Mol Life Sci 2009, 66:1350–1369.
Kindon H, Pothoulakis C, Thim L, et al.: Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 1995, 109:516–523.
Podolsky DK, Gerken G, Eyking A, et al.: Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 2009, 137:209–220.
Tomasetto C, Masson R, Linares J-S, et al.: pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 2000, 118:70–80.
Albert TK, Laubinger W, Müller S, et al.: Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-associated FCGBP protein and is released by hydrogen sulfide. J Proteome Res 2010 (Epub ahead of print).
Artis D, Wang ML, Keilbaugh SA, et al.: RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A 2004, 101:13596–13600.
Nair MG, Guild KJ, Du Y, et al.: Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation. J Immunol 2008, 181:4709–4715.
Hogan SP, Seidu L, Blanchard C, et al.: Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol 2006, 118:257–268.
Herbert DR, Yang JQ, Hogan SP, et al.: Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med 2009, 206:2947–2957.
Krimi RB, Kotelevets L, Dubuquoy L, et al.: Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm Bowel Dis 2008, 14:931–941.
Kobayashi K, Ogata H, Morikawa M, et al.: Distribution and partial characterisation of IgG Fc binding protein in various mucin producing cells and body fluids. Gut 2002, 51:169–176.
Knight PA, Brown JK, Pemberton AD: Innate immune response mechanisms in the intestinal epithelium: potential roles for mast cells and goblet cells in the expulsion of adult Trichinella spiralis. Parasitology 2008, 135:655–670.
•• Hasnain SZ, Wang H, Ghia JE, et al.: Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection. Gastroenterology 2010, 138:1763–1771. This recent study shows that mucin is an important component of innate defense in nematode infection in resistant, susceptible, and Muc2-deficient mice.
Ishikawa N, Horii Y, Oinuma T, et al.: Goblet cell mucins as the selective barrier for the intestinal helminths: T-cell-independent alteration of goblet cell mucins by immunologically ‘damaged’ Nippostrongylus brasiliensis worms and its significance on the challenge infection with homologous and heterologous parasites. Immunology 1994, 81:480–486.
Lidell ME, Moncada DM, Chadee K, et al.: Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. Proc Natl Acad Sci U S A 2006, 103:9298–9303.
Chin WC, Quesada I, Nguyen T, et al.: Oscillations of pH inside the secretory granule control the gain of Ca2+ release for signal transduction in goblet cell exocytosis. Novartis Found Symp 2002, 248:132–141; discussion 141–139, 277–182.
• Garcia MA, Yang N, Quinton PM: Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 2009, 119:2613–2622. This recent study provides evidence indicating that defective CFTR dependent-HCO3- secretion causes aggregated mucus in various organs in CF mice.
Thomsson KA, Hinojosa-Kurtzberg M, Axelsson KA, et al.: Intestinal mucins from cystic fibrosis mice show increased fucosylation due to an induced Fucalpha1-2 glycosyltransferase. Biochem J 2002, 367:609–616.
De Lisle RC, Roach E, Jansson K: Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007, 293:G577–G584.
Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427–434.
•• Heazlewood CK, Cook MC, Eri R, et al.: Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 2008, 5:e54. This report provides important evidence indicating that mucin misfolding can cause endoplasmic reticulum stress and can be a primary cause for pathogenesis of colitis.
Johansson MEV, Gustafsson JK, Sjöberg KE, et al.: Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PloS One 2010, in press.
•• An G, Wei B, Xia B, et al.: Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med 2007, 204:1417–1429. This is the first report describing the causal relationship between defective O-glycan synthesis and reduced Muc2 protein, defective intestinal barrier, and increased susceptibility to experimental colitis in mice.
Stone EL, Ismail MN, Lee SH, et al.: Glycosyltransferase function in core 2-type protein O glycosylation. Mol Cell Biol 2009, 29:3770–3782.
Tanaka H, Deng G, Matsuzaki K, et al.: BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer. Int J Cancer 2006, 118:2765–2771.
Kim DH, Kim JW, Cho JH, et al.: Expression of mucin core proteins, trefoil factors, APC and p21 in subsets of colorectal polyps and cancers suggests a distinct pathway of pathogenesis of mucinous carcinoma of the colorectum. Int J Oncol 2005, 27:957–964.